HiDef B8: Commercialization and scaled production of defined, robust, and cost-effective media for iPSCs

Project: Research project

Project Details


SCOPE OF WORK Northwestern University For the proposed application, Dr. Burridge’s lab will assess novel B8 derivatives for cell growth rate and maintenance of pluripotency.
Effective start/end date5/17/213/31/23


  • Defined Biosciences, Inc. (1R44GM140750-01A1//Burridge AGMT 8/26/21)
  • National Institute of General Medical Sciences (1R44GM140750-01A1//Burridge AGMT 8/26/21)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.